Literature DB >> 17720029

Real-world antipsychotic treatment practices.

Troy A Moore1, Nancy H Covell, Susan M Essock, Alexander L Miller.   

Abstract

This article examines real-world antipsychotic use in the treatment of schizophrenia by comparing real-world prescribing with medication algorithms and guidelines, by evaluating the evidence underlying recommendations and guidelines, and by examining the roles of side effects and medication adherence in real-world prescribing decisions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17720029     DOI: 10.1016/j.psc.2007.04.008

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  10 in total

Review 1.  Tactics and technologies to manage nonadherence in patients with schizophrenia.

Authors:  William M Glazer; Mathew J Byerly
Journal:  Curr Psychiatry Rep       Date:  2008-08       Impact factor: 5.285

Review 2.  A translational research approach to poor treatment response in patients with schizophrenia: clozapine-antipsychotic polypharmacy.

Authors:  William G Honer; Ric M Procyshyn; Eric Y H Chen; G William MacEwan; Alasdair M Barr
Journal:  J Psychiatry Neurosci       Date:  2009-11       Impact factor: 6.186

3.  The Differential Binding of Antipsychotic Drugs to the ABC Transporter P-Glycoprotein Predicts Cannabinoid-Antipsychotic Drug Interactions.

Authors:  Natalia I Brzozowska; Erik J de Tonnerre; Kong M Li; Xiao Suo Wang; Aurelie A Boucher; Paul D Callaghan; Michael Kuligowski; Alex Wong; Jonathon C Arnold
Journal:  Neuropsychopharmacology       Date:  2017-03-08       Impact factor: 7.853

4.  Reducing psychotropic pharmacotherapy in patients with severe mental illness: a cluster-randomized controlled intervention study.

Authors:  Peter Hjorth; Reinhold Kilian; Helle Østermark Sørensen; Susan Engelbrechsen Eriksen; Annette Sofie Davidsen; Signe Olrik Wallenstein Jensen; Povl Munk-Jørgensen
Journal:  Ther Adv Psychopharmacol       Date:  2015-04

5.  Prospective 8-week trial on the effect of olanzapine, quetiapine, and aripiprazole on blood glucose and lipids among individuals with first-onset schizophrenia.

Authors:  Shufen Zhang; Guanghua Lan
Journal:  Shanghai Arch Psychiatry       Date:  2014-12

6.  Quo Vadis Clozapine? A Bibliometric Study of 45 Years of Research in International Context.

Authors:  Francisco López-Muñoz; Javier Sanz-Fuentenebro; Gabriel Rubio; Pilar García-García; Cecilio Álamo
Journal:  Int J Mol Sci       Date:  2015-09-23       Impact factor: 5.923

7.  Antipsychotic prescribing patterns in Australia: a retrospective analysis.

Authors:  Nagesh Pai; Mustafa Acar; Prabhjot Juneja; Mahsa Hosseini Kouhkamari; Sinthuja Siva; Judy Mullan
Journal:  BMC Psychiatry       Date:  2022-02-12       Impact factor: 3.630

8.  Clozapine prescribing practice and trends in Qatar: First national observational study.

Authors:  Ovais Wadoo; Javed Latoo; Majid Alabdulla; Yassin Eltorki; Sadaf Riaz; Mustafa Abdul Karim; Mohammed Abu-Hafizah; Shuja Reagu
Journal:  Brain Behav       Date:  2022-06-01       Impact factor: 3.405

Review 9.  Clozapine: a review of clinical practice guidelines and prescribing trends.

Authors:  Stephanie Warnez; Silvia Alessi-Severini
Journal:  BMC Psychiatry       Date:  2014-04-07       Impact factor: 3.630

10.  Ziprasidone as adjunctive therapy in severe bipolar patients treated with clozapine.

Authors:  Natalia Bartolommei; Francesco Casamassima; Laura Pensabene; Federica Luchini; Antonella Benvenuti; Antonello Di Paolo; Luca Cosentino; Mauro Mauri; Lorenzo Lattanzi
Journal:  ISRN Psychiatry       Date:  2014-04-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.